Document

Advisory Committee to the Director, Centers for Disease Control and Prevention

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Preven...

PDF version Source Record

Department of Health and Human Services

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0001]

AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice of meeting and request for comment.

SUMMARY:

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC). This meeting is open to the public. The meeting will be webcast live via the World Wide Web.

DATES:

The meeting will be held on February 7, 2023, from 10 a.m. to 3:30 p.m., EST (times subject to change). The public may submit written comments on or before January 27, 2023.

ADDRESSES:

Information for accessing the webcast will be available at https://www.cdc.gov/about/advisory-committee-director/.

Written comments: You may submit comments, identified by Docket No. CDC-2023-0001, by any of the following methods. Do not submit comments for the docket by email. CDC does not accept comments for the docket by email.

Federal eRulemaking Portal:https://www.regulations.gov. Follow the instructions for submitting comments.
Mail: Kerry Caudwell, DPA, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027. Attn: Docket number CDC-2023-0001.

Instructions: All submissions received must include the Agency name and Docket Number. All relevant comments received in conformance with the https://www.regulations.gov suitability policy will be posted without change to https://www.regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to https://www.regulations.gov. Written public comments submitted up to 72 hours prior to the ACD meeting will be provided to ACD members before the meeting. Written comments received in advance of the meeting will be included in the official record of the meeting.

FOR FURTHER INFORMATION CONTACT:

Kerry Caudwell, DPA, Office of the ( printed page 1584) Chief of Staff, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone: (404) 639-0390; Email Address: ACDirector@cdc.gov.

SUPPLEMENTARY INFORMATION:

Purpose: The Advisory Committee to the Director (ACD), CDC, shall advise the Secretary, HHS, and the Director, CDC, on policy and broad strategies that will enable CDC to fulfill its mission of protecting health through health promotion, prevention, and preparedness. The committee recommends ways to prioritize CDC's activities, improve results, and address health disparities. It also provides guidance to help CDC work more effectively with its various private and public sector constituents to make health protection a practical reality.

M atters To Be Considered: The agenda will include discussions on CDC's current work and priorities as they relate to health equity and data and surveillance recommendations to the Department of Health and Human Services and CDC Director. The agenda also includes a laboratory workgroup update with recommended action steps to the full ACD Committee, along with an update on the public health infrastructure grant. Agenda items are subject to change as priorities dictate.

Public Participation

Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket.

The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,

Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2023-00408 Filed 1-10-23; 8:45 am]

BILLING CODE 4163-18-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

88 FR 1583

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Advisory Committee to the Director, Centers for Disease Control and Prevention,” thefederalregister.org (January 11, 2023), https://thefederalregister.org/documents/2023-00408/advisory-committee-to-the-director-centers-for-disease-control-and-prevention.